Tags

Type your tag names separated by a space and hit enter

Assessment of HPV DNA test value in management women with cytological findings of ASC-US, CIN1 and CIN2.
Coll Antropol. 2010 Mar; 34(1):81-6.CA

Abstract

The aim of this retrospective study was to answer the following questions: 1) is HPV DNA test for high-risk types able to predict lesion behaviour in women with cytological abnormalities lower than CIN3 (ASC-US, CIN1 and CIN2); 2) how to predict the histological diagnosis CIN3, and 3) is its use in diagnostic management in these patients justified or not? The study included 345 women (11 ASC-US, 312 CIN1 and 22 CIN2) that underwent conventional diagnostic management (repeat cytology and colposcopy with or without histology) and HPV testing for high-risk HPV types by PCR method. The value of HPVDNA test in predicting lesion regression/persistence was assessed in 275 subjects without histology. In 70 subjects, diagnostic accuracy (sensitivity, specificity, and positive and negative predictive value) of repeat cytology and HPV DNA test in predicting severe intraepithelial lesion (CIN3) was determined on the basis of colposcopy guided biopsy. The prevalence of persistent lesions was significantly higher in the group of HPV positive than in the group of HPV negative subjects (37.7% vs. 16.4%; p < 0.001). Positive HPV test was associated with a 3.1-fold risk of lesion persistence [OR (95% CI) = 3.095 (1.65-5.82)]. However, on screening to predict the outcome of cytologically diagnosed cervical lesion with sensitivity of 39.7% and positive predictive value of 37.7% showed that a positive test could not be considered a reliable indicator of lesion persistence. In contrast, the specificity of 82.5% and negative predictive value of 83.6% suggested that a negative test result could be taken as a good indicator of lesion regression. In comparison with repeat cytology, HPV test showed higher sensitivity (69.2% vs. 61.5%) but significantly lower specificity (63.2% vs. 93.0%) and positive predictive value (30.0% vs. 66.7%), and comparable negative predictive value (90.0% vs. 91.4%) in predicting histologically verified CIN3. In one patient with a histological diagnosis of squamous cell carcinoma with minimal invasion, repeat cytology indicated CIN3, whereas HPV test was negative. Due to authors experience in women with cytological abnormalities lower than CIN3, HPV testing is not a method to reliably predict lesion behaviour (regression, persistence) or presence of CIN3. HPV testing is of limited value in daily routine and should not be widely used until it is definitely demonstrated to be superior to conventional methods in improving the sensitivity, specificity and positive predictive value of CIN3 and invasive carcinoma detection.

Authors+Show Affiliations

Department of Clinical Cytology, University Hospital Center Osijek, Osijek, Croatia. pajtler.marija@kbo.hrNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

20432737

Citation

Pajtler, Marija, et al. "Assessment of HPV DNA Test Value in Management Women With Cytological Findings of ASC-US, CIN1 and CIN2." Collegium Antropologicum, vol. 34, no. 1, 2010, pp. 81-6.
Pajtler M, Milicić-Juhas V, Milojković M, et al. Assessment of HPV DNA test value in management women with cytological findings of ASC-US, CIN1 and CIN2. Coll Antropol. 2010;34(1):81-6.
Pajtler, M., Milicić-Juhas, V., Milojković, M., Topolovec, Z., Curzik, D., & Mihaljević, I. (2010). Assessment of HPV DNA test value in management women with cytological findings of ASC-US, CIN1 and CIN2. Collegium Antropologicum, 34(1), 81-6.
Pajtler M, et al. Assessment of HPV DNA Test Value in Management Women With Cytological Findings of ASC-US, CIN1 and CIN2. Coll Antropol. 2010;34(1):81-6. PubMed PMID: 20432737.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Assessment of HPV DNA test value in management women with cytological findings of ASC-US, CIN1 and CIN2. AU - Pajtler,Marija, AU - Milicić-Juhas,Valerija, AU - Milojković,Miodrag, AU - Topolovec,Zlatko, AU - Curzik,Darko, AU - Mihaljević,Ivan, PY - 2010/5/4/entrez PY - 2010/5/4/pubmed PY - 2010/5/21/medline SP - 81 EP - 6 JF - Collegium antropologicum JO - Coll Antropol VL - 34 IS - 1 N2 - The aim of this retrospective study was to answer the following questions: 1) is HPV DNA test for high-risk types able to predict lesion behaviour in women with cytological abnormalities lower than CIN3 (ASC-US, CIN1 and CIN2); 2) how to predict the histological diagnosis CIN3, and 3) is its use in diagnostic management in these patients justified or not? The study included 345 women (11 ASC-US, 312 CIN1 and 22 CIN2) that underwent conventional diagnostic management (repeat cytology and colposcopy with or without histology) and HPV testing for high-risk HPV types by PCR method. The value of HPVDNA test in predicting lesion regression/persistence was assessed in 275 subjects without histology. In 70 subjects, diagnostic accuracy (sensitivity, specificity, and positive and negative predictive value) of repeat cytology and HPV DNA test in predicting severe intraepithelial lesion (CIN3) was determined on the basis of colposcopy guided biopsy. The prevalence of persistent lesions was significantly higher in the group of HPV positive than in the group of HPV negative subjects (37.7% vs. 16.4%; p < 0.001). Positive HPV test was associated with a 3.1-fold risk of lesion persistence [OR (95% CI) = 3.095 (1.65-5.82)]. However, on screening to predict the outcome of cytologically diagnosed cervical lesion with sensitivity of 39.7% and positive predictive value of 37.7% showed that a positive test could not be considered a reliable indicator of lesion persistence. In contrast, the specificity of 82.5% and negative predictive value of 83.6% suggested that a negative test result could be taken as a good indicator of lesion regression. In comparison with repeat cytology, HPV test showed higher sensitivity (69.2% vs. 61.5%) but significantly lower specificity (63.2% vs. 93.0%) and positive predictive value (30.0% vs. 66.7%), and comparable negative predictive value (90.0% vs. 91.4%) in predicting histologically verified CIN3. In one patient with a histological diagnosis of squamous cell carcinoma with minimal invasion, repeat cytology indicated CIN3, whereas HPV test was negative. Due to authors experience in women with cytological abnormalities lower than CIN3, HPV testing is not a method to reliably predict lesion behaviour (regression, persistence) or presence of CIN3. HPV testing is of limited value in daily routine and should not be widely used until it is definitely demonstrated to be superior to conventional methods in improving the sensitivity, specificity and positive predictive value of CIN3 and invasive carcinoma detection. SN - 0350-6134 UR - https://www.unboundmedicine.com/medline/citation/20432737/Assessment_of_HPV_DNA_test_value_in_management_women_with_cytological_findings_of_ASC_US_CIN1_and_CIN2_ L2 - http://screening.iarc.fr/atlashisto.php DB - PRIME DP - Unbound Medicine ER -